UHS
54
-4
PSA
58
5
LOW
58
2
PCG
99
2
CNP
50
-2
JCI
61
-2
AON
60
2
ABT
57
-5
PM
58
2
GLW
48
-5
DIS
62
2
EQR
60
6
IP
70
-3
OXY
55
6
R
77
2
SIG
47
-2
AMAT
43
-5
TROW
51
-2
DOW
30
2
EMN
50
-2
UHS
54
-4
PSA
58
5
LOW
58
2
PCG
99
2
CNP
50
-2
JCI
61
-2
AON
60
2
ABT
57
-5
PM
58
2
GLW
48
-5
DIS
62
2
EQR
60
6
IP
70
-3
OXY
55
6
R
77
2
SIG
47
-2
AMAT
43
-5
TROW
51
-2
DOW
30
2
EMN
50
-2
Financhill
Back

Citius Oncology Vs. Neurogene Industry Stock Comparison

Sell
1

CTOR
Citius Oncology

Last Price:
1.09
Seasonality Move:
--
Sell
5

NGNE
Neurogene

Last Price:
39.96
Seasonality Move:
50.43%
Sell
1
Citius Oncology (CTOR) is a Sell

Is Citius Oncology a Buy, Sell or Hold?

  • The current Citius Oncology [CTOR] share price is $1.22. The Score for CTOR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • CTOR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
5
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CTOR Stock Price Chart

What is Citius Oncology's stock price today?

  • The Citius Oncology share price today is $1.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTOR is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $39.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

CTOR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 46.94 Sell
Chaikin Money Flow: -41402 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.07 - 1.27) Buy
Bollinger Bands (100): ( - ) Buy

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.3 Buy
Relative Strength Index (14 RSI): 39.1 Sell
Chaikin Money Flow: -346626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.29 - 61.53) Sell
Bollinger Bands (100): (34.11 - 50.51) Sell

CTOR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.23 Sell
20-day SMA: 1.21 Buy
50-day SMA: 1.34 Sell
200-day SMA: 0 Buy
8-day EMA: 1.24 Sell
20-day EMA: 1.23 Sell
50-day EMA: 1.41 Sell
200-day EMA: 0.1 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.39 Sell
20-day SMA: 53.17 Sell
50-day SMA: 46.66 Sell
200-day SMA: 38.93 Buy
8-day EMA: 54.03 Sell
20-day EMA: 53.18 Sell
50-day EMA: 48.36 Sell
200-day EMA: 38.47 Buy

Citius Oncology Earnings Growth & CTOR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Citius Oncology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):